{"response": {"meta": {"time": 98, "hits": 7, "offset": 0}, "docs": [{"news_desk": "Foreign Desk", "document_type": "article", "_id": "4fd2a5688eb7c8105d88cc4e", "headline": {"main": "Ah, Scotland! The Moors, the Braes, the Fried Pizza"}, "pub_date": "2004-12-07T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By LIZETTE ALVAREZ", "person": [{"lastname": "ALVAREZ", "rank": 1, "firstname": "Lizette", "organization": "", "role": "reported"}]}, "abstract": null, "web_url": "http://www.nytimes.com/2004/12/07/international/europe/07scotland.html", "section_name": "World; Health", "lead_paragraph": "As dinner sizzled and popped inside a vat of grease at Jaconelli's Fish and Chips, Deborah Ski, a customer eyeing the thick macaroni and cheese, did not mince words about Scotland's poor health. Smoking is one reason for Scotland's ''sick man of Europe'' tag, she said. But another was staring her in the face: deep fried pizza, covered in a coating of batter for added crunch, sometimes doused with salt and vinegar or soupy gravy.", "snippet": "The Labor leader who heads the Scottish government has made the state of his country's health a priority.", "blog": [], "keywords": [{"value": "SCOTLAND", "name": "glocations"}, {"value": "MEDICINE AND HEALTH", "name": "subject"}, {"value": "SMOKING AND TOBACCO", "name": "subject"}, {"value": "FOOD", "name": "subject"}], "print_page": "3", "type_of_material": "News", "word_count": 1137, "subsection_name": null, "multimedia": [{"legacy": {"thumbnailheight": 75, "hasthumbnail": "Y", "thumbnail": "images/2004/12/07/international/scotland.7575.jpg"}, "height": 75, "type": "image", "url": "images/2004/12/07/international/scotland.7575.jpg", "subtype": "thumbnail"}]}, {"news_desk": "Outlook", "document_type": "article", "_id": "4fd241498eb7c8105d7d9606", "headline": {"main": "Advertising; With or Without Vioxx, Drug Ads Proliferate"}, "pub_date": "2004-12-06T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By STUART ELLIOTT", "person": [{"lastname": "ELLIOTT", "rank": 1, "firstname": "Stuart", "organization": "", "role": "reported"}]}, "abstract": "Drug companies now outspend giant consumer products companies in advertising prescription drugs directly to consumers; are concerned that recall of arthritis pain killer Vioxx will make consumers sceptical about safety of advertised drugs; photo (M)", "web_url": "http://www.nytimes.com/2004/12/06/business/businessspecial2/06adco.html", "section_name": "Health", "lead_paragraph": "JUST seven years after the Food and Drug Administration ended decades of restrictions by allowing drug makers to advertise prescription products directly to consumers, spending on such ads has reached $3.8 billion. To put that sum in perspective, it is more than companies like Coca-Cola, Pepsi-Cola and Cadbury Schweppes spend combined each year to sell their soft drinks. It even exceeds what one of the very largest marketers, Unilever, spends annually on global campaigns for all its brands, including Dove, Knorr, Lipton, Lux, Pond's, Slim-Fast and Wish-Bone.", "snippet": "The pharmaceutical industry and Madison Avenue are increasingly concerned about their ability to continue to pitch prescription drugs at patients and doctors.", "blog": [], "keywords": [{"value": "ADVERTISING (TIMES COLUMN)", "name": "creative_works"}, {"value": "FOOD AND DRUG ADMINISTRATION", "name": "organizations"}, {"value": "MARKETING AND MERCHANDISING", "name": "subject"}, {"value": "ADVERTISING AND MARKETING", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "ARTHRITIS AND RHEUMATISM", "name": "subject"}, {"value": "CONSUMER PROTECTION", "name": "subject"}, {"value": "MEDICINE AND HEALTH", "name": "subject"}, {"value": "RECALLS AND BANS OF PRODUCTS", "name": "subject"}, {"value": "VIOXX (DRUG)", "name": "subject"}], "print_page": "17", "type_of_material": "News", "word_count": 959, "subsection_name": null, "multimedia": []}, {"news_desk": "SundayBusiness", "document_type": "article", "_id": "4fd2a5678eb7c8105d88cbed", "headline": {"main": "Is the Low-Carb Boom Over?"}, "pub_date": "2004-12-05T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By MELANIE WARNER", "person": [{"lastname": "WARNER", "rank": 1, "firstname": "Melanie", "organization": "", "role": "reported"}]}, "abstract": "Article on general malaise that is overtaking low-carb boom in America; some 3,737 products, including new flavors and varieties of existing foods, have been introduced in last two years but manufacturers are reporting sharp decline in orders and sharp increase in inventories; many food industry analysts say low-carb movement, if not dead, is at least deeply wounded; photos; graph (L)", "web_url": "http://www.nytimes.com/2004/12/05/business/yourmoney/05atki.html", "section_name": "Health; Business", "lead_paragraph": "LAST July, executives of the American Italian Pasta Company decamped at the Atkins Nutritionals office in midtown Manhattan, determined to cook up a new blockbuster product. They spent several days hammering out a deal to put the Atkins name on a line of low-carbohydrate, soy-based pasta. It was the latest food group to be Atkinized. The two companies seemed certain that soy pasta, with 5 to 10 grams per serving of what manufacturers call ''net carbs,'' would be a hit. Regular pasta contains up to 45 grams of carbohydrates, so the new product would offer a great way for people on Atkins and other low-carb regiments to indulge -- free of guilt -- in fettuccine Alfredo and baked ziti. Atkins allotted $15 million for a campaign to announce the introduction.", "snippet": "A general malaise is overtaking what was once the hottest - and still the most controversial - trend in the food business.", "blog": [], "keywords": [{"value": "CARBOHYDRATES", "name": "subject"}, {"value": "PASTA", "name": "subject"}, {"value": "MEDICINE AND HEALTH", "name": "subject"}, {"value": "GRAIN", "name": "subject"}, {"value": "FOOD", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 2677, "subsection_name": null, "multimedia": []}, {"news_desk": "National Desk", "document_type": "article", "_id": "4fd280958eb7c8105d84bca8", "headline": {"main": "Will a New Drug Melt the Pounds? It May, but Doctors Urge Caution"}, "pub_date": "2004-12-05T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By GINA KOLATA", "person": [{"lastname": "KOLATA", "rank": 1, "firstname": "Gina", "organization": "", "role": "reported"}]}, "abstract": "Medical researchers caution overweight people who are already pinning hope of losing weight on new drug called rimonabant, which has not yet been approved for sale in United States or anywhere else; note lack of any published studies from clinical trials to justify any of claims for what some patients are already calling a miracle drug; its maker, Sanofi-Aventis, has not yet submitted its application for marketing to Food and Drug Administration; description of how rimonabant works; photos (M)", "web_url": "http://www.nytimes.com/2004/12/05/health/05miracle.html", "section_name": "Health; U.S.", "lead_paragraph": "To people who have struggled for a lifetime to lose weight, the new drug called rimonabant sounds like a dream come true. It will make a person uninterested in fattening foods, they have heard from news reports and word of mouth. Weight will just melt away, and fat accumulating around the waist and abdomen will be the first to go. And by the way, those who take it will end up with higher levels of H.D.L., the good cholesterol. If they smoke, they will find it easier to quit. If they are heavy drinkers, they will no longer crave alcohol.", "snippet": "While rimonabant sounds like a dream come true to people who are trying to lose weight, some researchers say the drug may be getting more attention than it deserves.", "blog": [], "keywords": [{"value": "SANOFI-AVENTIS", "name": "organizations"}, {"value": "FOOD AND DRUG ADMINISTRATION", "name": "organizations"}, {"value": "DIET AND NUTRITION", "name": "subject"}, {"value": "WEIGHT", "name": "subject"}, {"value": "DRUGS (PHARMACEUTICALS)", "name": "subject"}, {"value": "OBESITY", "name": "subject"}, {"value": "MEDICINE AND HEALTH", "name": "subject"}, {"value": "RIMONABANT (DRUG)", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 1449, "subsection_name": null, "multimedia": []}, {"news_desk": "Dining In, Dining Out/Style Desk", "document_type": "article", "_id": "4fd241478eb7c8105d7d94c1", "headline": {"kicker": "EATING WELL", "main": "Read Any Good Nutrition Labels Lately?"}, "pub_date": "2004-12-01T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By Marian Burros", "person": [{"lastname": "Burros", "rank": 1, "firstname": "Marian", "organization": "", "role": "reported"}]}, "abstract": "Marian Burros Eating Well article examines data on Americans' use of mandatory nutrition labeling for packaged foods; says many people look only to see amount of fat, or focus on specific nutrients; nutrition Prof Jeanne P Goldberg warns that people are getting nuggets of information, but not using data to establish more healthful eating habits; FDA says it wants to initiate consumer education campaign focusing on 'calories count' message; photo (M)", "web_url": "http://www.nytimes.com/2004/12/01/dining/01LABE.html", "section_name": "Dining and Wine; Style", "lead_paragraph": "WHEN mandatory nutrition labeling for packaged foods became the law of the land in 1994, the government predicted that Americans would routinely use it and that it would improve their eating habits. Give the government credit for getting it half right. Even as the country gets fatter and fatter, people say they do look at the nutrition facts panel on packaged foods. In a telephone survey of 554 adults nationwide by The New York Times, 85 percent of the respondents said they read the label closely some or all of the time. About 66 percent said they had used information to decide whether or not to buy something.", "snippet": "Even as the country gets fatter and fatter, people say they do look at the nutrition facts panel on packaged foods.", "blog": [], "keywords": [{"value": "GOLDBERG, JEANNE P", "name": "persons"}, {"value": "FOOD AND DRUG ADMINISTRATION", "name": "organizations"}, {"value": "DIET AND NUTRITION", "name": "subject"}, {"value": "PUBLIC OPINION", "name": "subject"}, {"value": "CALORIES", "name": "subject"}, {"value": "LABELING AND LABELS", "name": "subject"}, {"value": "CONSUMER PROTECTION", "name": "subject"}, {"value": "OILS AND FATS", "name": "subject"}, {"value": "FOOD", "name": "subject"}], "print_page": "1", "type_of_material": "News", "word_count": 1510, "subsection_name": null, "multimedia": [{"legacy": {"thumbnailheight": 75, "hasthumbnail": "Y", "thumbnail": "images/2004/11/30/dining/01well75.jpg"}, "height": 75, "type": "image", "url": "images/2004/11/30/dining/01well75.jpg", "subtype": "thumbnail"}, {"legacy": {"hastinythumb": "Y", "tinythumbheight": 55, "tinythumbwidth": 55}, "height": 55, "type": "image", "width": 55, "subtype": "tiny_thumb"}]}, {"news_desk": "National Desk", "document_type": "article", "_id": "4fd280938eb7c8105d84bbb5", "headline": {"main": "National Briefing | South: Alabama: Insurer Seeks New Rules For Gastric Bypasses"}, "pub_date": "2004-12-01T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By Ariel Hart (NYT)", "person": [{"middlename": "Hart", "organization": "", "role": "reported", "rank": 1, "firstname": "Ariel", "lastname": "NYT"}]}, "abstract": "Blue Cross and Blue Shield of Alabama, largest health insurer in state with extremely high obesity rate, suspends coverage of gastric-bypass surgery while it writes new rules to make sure that surgery is performed on patients for whom it most likely to be successful (S)", "web_url": "http://query.nytimes.com/gst/fullpage.html?res=940CEFDF1E3EF932A35751C1A9629C8B63", "section_name": "Health; U.S.", "lead_paragraph": "Blue Cross and Blue Shield of Alabama, the largest health insurer in the state with an extremely high obesity rate, has suspended coverage of gastric-bypass surgery while it writes new rules to make sure the surgery is performed on patients for whom it is most likely to be successful, a spokesman, Jim Brown, said. Physicians involved in a comment period said the insurer was considering years of weight monitoring and a six-month supervised diet before approving a bypass. Ariel Hart (NYT)", "snippet": "Blue Cross and Blue Shield of Alabama, the largest health insurer in the state with an extremely high obesity rate, has suspended coverage of gastric-bypass surgery while it writes new rules to make sure the surgery is performed on patients for whom...", "blog": [], "keywords": [{"value": "ALABAMA", "name": "glocations"}, {"value": "BLUE CROSS AND BLUE SHIELD OF ALABAMA", "name": "organizations"}, {"value": "WEIGHT", "name": "subject"}, {"value": "SURGERY AND SURGEONS", "name": "subject"}], "print_page": "22", "type_of_material": "News", "word_count": 81, "subsection_name": null, "multimedia": []}, {"news_desk": "Metropolitan Desk", "document_type": "article", "_id": "4fd2a5648eb7c8105d88cabc", "headline": {"kicker": "PUBLIC LIVES", "main": "Helping Life Into the World, Then Trying to Save It"}, "pub_date": "2004-12-01T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By MARC SANTORA", "person": [{"lastname": "SANTORA", "rank": 1, "firstname": "Marc", "organization": "", "role": "reported"}]}, "abstract": "Interview with Dr Allan Rosenfield, dean of Columbia University's Mailman School for Public Health since 1986, who discusses his work treating poor women in Africa and Asia and particularly fight against AIDS among women, who make up roughly half of 39.4 million affected people affected worldwide; photo (M)", "web_url": "http://www.nytimes.com/2004/12/01/nyregion/01profile.html", "section_name": "New York and Region", "lead_paragraph": "THE trade-off was not an easy one, but then again, it was never really a choice for Dr. Allan Rosenfield. Like his father before him, Dr. Rosenfield was trained to help bring life into this world as an obstetrician. But, since graduating from medical school, he has been drawn to keeping those already in the world alive.", "snippet": "Columbia University's Dr. Allan Rosenfield is involved in one of the toughest fights on earth, the battle against the global AIDS pandemic.", "blog": [], "keywords": [{"value": "ROSENFIELD, ALLAN", "name": "persons"}, {"value": "GATES, BILL", "name": "persons"}, {"value": "FAR EAST, SOUTH AND SOUTHEAST ASIA AND PACIFIC AREAS", "name": "glocations"}, {"value": "AFRICA", "name": "glocations"}, {"value": "COLUMBIA UNIVERSITY", "name": "organizations"}, {"value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME", "name": "subject"}, {"value": "BIOGRAPHICAL INFORMATION", "name": "subject"}, {"value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)", "name": "subject"}, {"value": "WOMEN", "name": "subject"}], "print_page": "2", "type_of_material": "Biography", "word_count": 884, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}